根据美国动脉粥样硬化性心血管疾病的风险，他汀类药物的适格性

IF 14.1 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JAMA cardiology Pub Date : 2025-08-20 DOI:10.1001/jamacardio.2025.2725

Sadiya S. Khan, Xiaoning Huang, Chiadi E. Ndumele, Roger S. Blumenthal, Michael J. Pencina, Allan D. Sniderman, Nilay S. Shah, John T. Wilkins, Donald M. Lloyd-Jones

引用次数: 0

摘要

本横断面研究评估了使用预测心血管疾病事件风险标准评估10年动脉粥样硬化性心血管疾病风险评估的意义。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US

This cross-sectional study evaluates the implications of using the Predicting Risk of Cardiovascular Disease Events criteria to assess 10-year atherosclerotic cardiovascular disease risk estimates.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JAMA cardiology Medicine-Cardiology and Cardiovascular Medicine

CiteScore

45.80

自引率

1.70%

发文量

264

期刊介绍： JAMA Cardiology, an international peer-reviewed journal, serves as the premier publication for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. As a member of the JAMA Network, it aligns with a consortium of peer-reviewed general medical and specialty publications. Published online weekly, every Wednesday, and in 12 print/online issues annually, JAMA Cardiology attracts over 4.3 million annual article views and downloads. Research articles become freely accessible online 12 months post-publication without any author fees. Moreover, the online version is readily accessible to institutions in developing countries through the World Health Organization's HINARI program. Positioned at the intersection of clinical investigation, actionable clinical science, and clinical practice, JAMA Cardiology prioritizes traditional and evolving cardiovascular medicine, alongside evidence-based health policy. It places particular emphasis on health equity, especially when grounded in original science, as a top editorial priority.